반응식
[CH3:1][C:2]([CH3:31])([CH3:30])[C@H:3]([NH:8][C:9]([N:11]1[C:19]2[CH2:18][CH2:17]N(C)C[C:14]=2[C:13]([C:21]2[CH:26]=[C:25]([F:27])[C:24]([F:28])=[CH:23][C:22]=2F)=[N:12]1)=[O:10])[C:4]([NH:6][CH3:7])=[O:5].[C:32]([N:39]1CCC(=O)[CH2:41][CH2:40]1)(OC(C)(C)C)=O.O=C1CCCCN(C(OC(C)(C)C)=O)C1.FC1C=C(F)C(F)=CC=1C(Cl)=O.FC1C=C(C=CC=1F)C(Cl)=O>>[F:27][C:25]1[CH:26]=[C:21]([C:13]2[C:14]3[N:39]([CH3:32])[CH2:40][CH2:41][CH2:17][CH2:18][C:19]=3[N:11]([C:9]([NH:8][C@@H:3]([C:2]([CH3:1])([CH3:30])[CH3:31])[C:4]([NH:6][CH3:7])=[O:5])=[O:10])[N:12]=2)[CH:22]=[CH:23][C:24]=1[F:28]참가 물질
6
반응물 5
생성물 1
실험 절차
Compound 69 was prepared according to the procedure described above for the synthesis of compound 37 except that 1-Boc-4-piperidone was replaced with tert-butyl 3-oxoazepane-1-carboxylate and 2,4,5-trifluorobenzoyl-chloride was replaced with 3,4-difluorobenzoylchloride. LCMS (+ESI) m/z=434.2 [M+H]+.
출처 및 근거
- ORD 기록
- ord-40bdf287a2a14cebb12d18199dcae4fe
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08653127B2
연결된 노트
불러오는 중…